In?vivo murine and in?vitro M-like cell models of gastrointestinal anthrax

详细信息    查看全文

• 作者：Jessica H. Tonry¹ ; ^{jessica.chertow@nih.gov} ; Serguei G. Popov ; Aarthi Narayanan ; Fatah Kashanchi ; Ramin M. Hakami ; Calvin Carpenter ; Charles Bailey ; Myung-Chul Chung ; ^{mchung3@gmu.edu}
• 关键词：Gastrointestinal (GI) anthrax ; M-like cell ; Murine model ; Bacillus anthracis
• 刊名：Microbes and Infection
• 出版年：2013
• 出版时间：January, 2013
• 年：2013
• 卷：15
• 期：1
• 页码：37-44
• 全文大小：960 K

文摘

Bacillus anthracis is the causative agent of anthrax and is acquired by three routes of infection: inhalational, gastrointestinal and cutaneous. Gastrointestinal (GI) anthrax is rare, but can rapidly result in severe, systemic disease that is fatal in 25 % -60 % of cases. Disease mechanisms of GI anthrax remain unclear due to limited numbers of clinical cases and the lack of experimental animal models. Here, we developed an in?vivo murine model of GI anthrax where spore survival was maximized through the neutralization of stomach acid followed by an intragastric administration of a thiabendazole paste spore formulation. Infected mice showed a dose-dependent mortality rate and pathological features closely mimicking human GI anthrax. Since Peyer's patches in the murine intestine are the primary sites of B. anthracis growth, we developed a human M (microfold)-like-cell model using a Caco-2/Raji B-cell co-culturing system to study invasive mechanisms of GI anthrax across the intestinal epithelium. Translocation of B. anthracis spores was higher in M-like cells than Caco-2 monolayers, suggesting that M-like cells may serve as an initial entry site for spores. Here, we developed an in?vivo murine model of GI anthrax and an in?vitro M-like cell model that could be used to further our knowledge of GI anthrax pathogenesis.